These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9723634)

  • 21. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
    Tang WH; Vagelos RH; Yee YG; Benedict CR; Willson K; Liss CL; Fowler MB
    J Am Coll Cardiol; 2002 Jan; 39(1):70-8. PubMed ID: 11755289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.
    van Vliet AA; Donker AJ; Nauta JJ; Verheugt FW
    Am J Cardiol; 1993 Jan; 71(3):21A-28A. PubMed ID: 8422000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE inhibitor dosage at the time of listing predicts survival.
    Berger R; Kuchling G; Frey B; Kozanly I; Pacher R; Stanek B
    J Heart Lung Transplant; 2000 Feb; 19(2):127-33. PubMed ID: 10703687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure.
    Dutertre JP; Billaud EM; Autret E; Chantepie A; Oliver I; Laugier J
    Br J Clin Pharmacol; 1993 May; 35(5):528-30. PubMed ID: 8512763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
    Crozier I; Ikram H
    Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing and emergency admissions for heart failure in greater Glasgow.
    Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
    J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH; Dooley DJ; Fonarow GC; Butler J; Bhatt DL; Filippatos GS; Deedwania P; Forman DE; White M; Fletcher RD; Arundel C; Blackman MR; Adamopoulos C; Kanonidis IE; Aban IB; Patel K; Aronow WS; Allman RM; Anker SD; Pitt B; Ahmed A
    Eur J Heart Fail; 2018 Feb; 20(2):359-369. PubMed ID: 28980368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors.
    Guazzi M; Pontone G; Agostoni P
    Am Heart J; 1999 Aug; 138(2 Pt 1):254-60. PubMed ID: 10426836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators.
    Eur Heart J; 1998 Mar; 19(3):481-9. PubMed ID: 9568453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.
    Jensen BV; Nielsen SL; Skovsgaard T
    Lancet; 1996 Feb; 347(8997):297-9. PubMed ID: 8569365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.
    Nanas JN; Alexopoulos G; Anastasiou-Nana MI; Karidis K; Tirologos A; Zobolos S; Pirgakis V; Anthopoulos L; Sideris D; Stamatelopoulos SF; Moulopoulos SD
    J Am Coll Cardiol; 2000 Dec; 36(7):2090-5. PubMed ID: 11127445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
    Pomini G; Rugna A; Lupia M; Opocher G; Gribaldo R
    G Ital Cardiol; 1992 Jul; 22(7):807-12. PubMed ID: 1473654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure.
    McMurray J; Lang CC; Maclean DD; McDevitt DG; Struthers AD
    Scott Med J; 1989 Apr; 34(2):425-7. PubMed ID: 2740888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.